Jupiter Life Line Hospitals Ltd.(IN:JLHL)
₹289.35-1.10 (-0.38%)
IN:JLHL
Jupiter Life Line Hospitals Ltd. financials statements
₹289.35
At close:-1.10 (-0.38%)
Want to see IN:JLHL full AI Analyst Report?
Jupiter Life Line Hospitals Ltd. (JLHL) Ratios
0 Followers
Jupiter Life Line Hospitals Ltd. Ratios
IN:JLHL's free cash flow for Q2 2027 was ₹0.00. For the 2027 fiscal year, IN:JLHL's free cash flow was increased by ₹0.00 and operating cash flow was ₹0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.02 | 4.51 | 3.87 | 1.58 | 1.46 |
| Quick Ratio | 2.85 | 4.35 | 3.67 | 1.44 | 1.34 |
| Cash Ratio | 0.26 | 0.61 | 2.85 | 1.02 | 0.84 |
| Solvency Ratio | 0.34 | 0.46 | 1.94 | 0.18 | 0.14 |
| Operating Cash Flow Ratio | 1.18 | 1.66 | 1.08 | 0.89 | 1.11 |
| Short-Term Operating Cash Flow Coverage | 15.03 | 63.84 | 0.00 | 7.27 | 4.46 |
| Net Current Asset Value | ₹ -1.54B | ₹ 1.38B | ₹ 2.97B | ₹ -4.12B | ₹ -4.40B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.25 | 0.21 | 0.05 | 0.48 | 0.55 |
| Debt-to-Equity Ratio | 0.38 | 0.29 | 0.05 | 1.28 | 1.69 |
| Debt-to-Capital Ratio | 0.27 | 0.22 | 0.05 | 0.56 | 0.63 |
| Long-Term Debt-to-Capital Ratio | 0.24 | 0.19 | 0.00 | 0.55 | 0.61 |
| Financial Leverage Ratio | 1.54 | 1.40 | 1.10 | 2.70 | 3.10 |
| Debt Service Coverage Ratio | 5.49 | 17.98 | 9.19 | 2.57 | 1.66 |
| Interest Coverage Ratio | 7.83 | 22.70 | 7.52 | 3.88 | 2.69 |
| Debt to Market Cap | 0.06 | 0.03 | 0.00 | 0.07 | 0.07 |
| Interest Debt Per Share | 18.80 | 12.32 | 14.40 | 77.92 | 82.23 |
| Net Debt to EBITDA | 1.53 | 0.92 | -0.92 | 1.62 | 2.61 |
| Profitability Margins | |||||
| Gross Profit Margin | 57.91% | 81.76% | 79.99% | 79.70% | 55.55% |
| EBIT Margin | 17.04% | 21.26% | 20.39% | 18.76% | 15.52% |
| EBITDA Margin | 22.89% | 25.78% | 24.40% | 23.08% | 20.45% |
| Operating Profit Margin | 17.04% | 18.99% | 18.53% | 18.35% | 16.14% |
| Pretax Profit Margin | 17.36% | 20.43% | 18.27% | 14.42% | 10.52% |
| Net Profit Margin | 12.95% | 15.31% | 16.51% | 8.17% | 6.97% |
| Continuous Operations Profit Margin | 12.95% | 15.34% | 16.51% | 8.17% | 6.97% |
| Net Income Per EBT | 74.56% | 74.97% | 90.38% | 56.64% | 66.30% |
| EBT Per EBIT | 101.88% | 107.56% | 98.59% | 78.57% | 65.16% |
| Return on Assets (ROA) | 8.15% | 10.14% | 13.78% | 7.40% | 5.63% |
| Return on Equity (ROE) | 12.58% | 14.25% | 15.11% | 19.94% | 17.42% |
| Return on Capital Employed (ROCE) | 11.85% | 13.67% | 16.86% | 19.20% | 15.07% |
| Return on Invested Capital (ROIC) | 8.77% | 10.21% | 15.24% | 10.67% | 9.61% |
| Return on Tangible Assets | 8.18% | 10.17% | 13.81% | 7.40% | 5.63% |
| Earnings Yield | 2.31% | 1.89% | 2.41% | 1.03% | 0.72% |
| Efficiency Ratios | |||||
| Receivables Turnover | 19.85 | 29.85 | 18.52 | 19.31 | 16.52 |
| Payables Turnover | 6.61 | 2.24 | 3.44 | 2.56 | 5.33 |
| Inventory Turnover | 16.47 | 9.55 | 10.03 | 9.53 | 21.22 |
| Fixed Asset Turnover | 1.00 | 1.09 | 1.35 | 1.19 | 1.03 |
| Asset Turnover | 0.63 | 0.66 | 0.83 | 0.91 | 0.81 |
| Working Capital Turnover Ratio | 3.02 | 3.01 | 5.61 | 13.29 | 19.77 |
| Cash Conversion Cycle | -14.69 | -112.76 | -50.04 | -85.33 | -29.15 |
| Days of Sales Outstanding | 18.38 | 12.23 | 19.71 | 18.90 | 22.10 |
| Days of Inventory Outstanding | 22.17 | 38.22 | 36.40 | 38.28 | 17.20 |
| Days of Payables Outstanding | 55.24 | 163.20 | 106.15 | 142.51 | 68.45 |
| Operating Cycle | 40.55 | 50.45 | 56.11 | 57.18 | 39.30 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 8.16 | 7.73 | 18.60 | 17.87 | 20.89 |
| Free Cash Flow Per Share | -7.14 | -2.06 | 4.75 | 6.09 | 6.90 |
| Dividend Paid and CapEx Coverage Ratio | 0.53 | 0.77 | 1.26 | 1.42 | 1.49 |
| Capital Expenditure Coverage Ratio | 0.53 | 0.79 | 1.34 | 1.52 | 1.49 |
| Operating Cash Flow Coverage Ratio | 0.46 | 0.64 | 1.84 | 0.25 | 0.28 |
| Operating Cash Flow to Sales Ratio | 0.18 | 0.20 | 0.11 | 0.13 | 0.19 |
| Free Cash Flow Yield | -2.78% | -0.66% | 0.40% | 0.57% | 0.64% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 43.28 | 53.04 | 41.58 | 96.75 | 137.95 |
| Price-to-Sales (P/S) Ratio | 5.61 | 8.12 | 6.87 | 7.90 | 9.62 |
| Price-to-Book (P/B) Ratio | 5.45 | 7.55 | 6.28 | 19.29 | 24.03 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -35.91 | -151.89 | 251.27 | 176.67 | 155.91 |
| Price-to-Operating Cash Flow Ratio | 31.41 | 40.43 | 64.12 | 60.20 | 51.49 |
| Price-to-Earnings Growth (PEG) Ratio | 84.98 | 15.09 | 0.27 | 2.27 | -0.06 |
| Enterprise Value Multiple | 26.03 | 32.41 | 27.22 | 35.86 | 49.66 |
| Enterprise Value | 89.34B | 105.42B | 71.05B | 73.87B | 74.45B |
| EV to EBITDA | 26.03 | 32.41 | 27.22 | 35.86 | 49.66 |
| EV to Sales | 5.96 | 8.36 | 6.64 | 8.28 | 10.16 |
| EV to Free Cash Flow | -38.16 | -156.35 | 243.09 | 185.04 | 164.57 |
| EV to Operating Cash Flow | 33.37 | 41.62 | 62.04 | 63.05 | 54.36 |
| Tangible Book Value Per Share | 46.81 | 41.24 | 189.48 | 55.39 | 43.86 |
| Shareholders’ Equity Per Share | 47.06 | 41.38 | 189.87 | 55.77 | 44.77 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.25 | 0.25 | 0.10 | 0.43 | 0.34 |
| Revenue Per Share | 45.71 | 38.49 | 173.70 | 136.13 | 111.81 |
| Net Income Per Share | 5.92 | 5.89 | 28.68 | 11.12 | 7.80 |
| Tax Burden | 0.75 | 0.75 | 0.90 | 0.57 | 0.66 |
| Interest Burden | 1.02 | 0.96 | 0.90 | 0.77 | 0.68 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.24 | 0.25 | 0.25 | 0.24 | 0.24 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.38 | 0.98 | 0.65 | 0.91 | 1.78 |
Currency in INR

